Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Y-mAbs Therapeutics, Inc. (YMAB)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Mar-31-20Dec-31-19Mar-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K8-K10-K8-K10-K10-KS-1/A
Total revenues   [+]34.920.818.60.012.50.00.013.9
            Revenue growth  68.2% 48.8%   -100.0% 
Cost of goods sold  2.32.226.70.016.30.00.017.0
Gross profit  32.618.5-8.10.0-3.70.00.0-3.2
            Gross margin  93.4%89.4%-43.6% -29.9%  -23.0%
Selling, general and administrative   [+]54.644.88.119.53.79.04.93.2
Research and development  93.293.7 63.5 34.314.3 
Other operating expenses  -61.8 10.5 8.8  10.7
EBITDA   [+]-52.6-119.5 -82.8 -43.2  
            EBITDA margin  -150.8%-576.1%-143.6% -129.9%  -123.0%
Depreciation and amortization  0.80.4 0.2 0.0  
EBIT   [+]-53.4-119.9-26.7-83.0-16.3-43.2-19.2-17.0
            EBIT margin  -153.1%-578.0%-143.6% -129.9%  -123.0%
Non-recurring items   [+]62.0       
Other income (expense), net  60.20.60.62.00.30.00.10.0
Pre-tax income  -55.3-119.3-26.2-81.0-15.9-43.3-19.2-17.1
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -55.3-119.3-26.2-81.0-15.9-43.3-19.20.0
            Net margin  -158.4%-575.1%-140.6% -127.4%  -0.1%
   
Basic EPS   [+]($1.28)($2.97)($0.66)($2.30)($0.47)($1.50)($0.99)($1.21)
Diluted EPS   [+]($1.28)($2.97)($0.66)($2.30)($0.47)($1.50)($0.99)($1.21)
   
Shares outstanding (basic)   [+]43.240.139.835.234.228.819.40.0
Shares outstanding (diluted)   [+]43.240.139.835.234.228.819.40.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy